وی این جی او سی این وائی این جی او سی اور یو این او ڈی سی سول سوسائٹی یونٹ کے ساتھ مل کر 31 جنوری 2023 کو صبح 8.30 بجے ای سی او ایس او سی پارٹنرشپ فورم 2023 کے حاشیے میں ایک آن لائن سائیڈ ایونٹ کا انعقاد کر رہا ہے۔ اس تقریب کا عنوان ہے: منشیات کی پالیسیوں، کوویڈ 19 اور 2030 ایجنڈے کے حصول میں سول سوسائٹی کا مرکزی کردار

Brief Description:

The Executive Secretariat of the Inter-American Drug Abuse Control Commission (ES-CICAD) is seeking expressions of interest from experts in the field of alternatives to incarceration and social integration to be trained as Master Trainers for the delivery of the Case Care Management curriculum internationally. Upon successful completion of the Training of Trainers, these Master Trainers will be included on the Case Care Management roster of trainers and can be contacted to deliver the training when scheduled. If interested, please submit your resume and relevant...

Dear friends and colleagues, 

The Commission on Narcotic Drugs is starting very soon! In fact, tomorrow, Monday, 14 March 2022. 

Once again, all sessions, as well as the side events, are to be held online due to the pandemic. The good thing about that means that, you can still follow the plenaries and the side events! That’s why we thought that you might appreciate having all the links in one place.

GENERAL LINKS TO FOLLOW CND

• Link to 65th session with general information on organizational arrangements: https://www.unodc.org/unodc/en/commissions/CND/session/65_Session_2022/65CND...

Hybrid effectiveness-implementation trial designs have become increasingly prevalent in implementation research. As hybrid designs enter their second decade of widespread use, the Frontiers in Health Services’ Implementation Science section launches a Research Topic to fuel the field’s discourse on the past, present, and future of hybrid designs in knowledge translation. Submissions are welcome of both Original and/or Brief Research, Review, Methods, and Perspective articles. The call addresses critical assessments of hybrid designs, innovative use of hybrid designs in current trials, and...